Inventor · disambiguated record
Eliel Bayever
Also filed as: BAYEVER ELIEL
9 granted patents·18 pending applications·90 citations·filing 2005–2025
90Inventor score
Top patents by PatentIndex Score
27 records- 0197US9717724B2Methods for treating pancreatic cancer using combination therapiesIPSEN BIOPHARM LTD·Filed 2016·Granted Aug 1, 2017·14 cites·24 claims
- 0296US10980795B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanIPSEN BIOPHARM LTD·Filed 2018·Granted Apr 20, 2021·8 cites·15 claims
- 0396US9492442B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Nov 15, 2016·19 cites·30 claims
- 0495US9339497B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted May 17, 2016·17 cites·27 claims
- 0594US9364473B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Jun 14, 2016·12 cites·29 claims
- 0693US11369597B2Methods for treating pancreatic cancer using combination therapiesIPSEN BIOPHARM LTD·Filed 2018·Granted Jun 28, 2022·4 cites·13 claims
- 0792US9452162B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2013·Granted Sep 27, 2016·12 cites·35 claims
- 0890US11344552B2Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatinIPSEN BIOPHARM LTD·Filed 2017·Granted May 31, 2022·4 cites·15 claims
- 0989US2024226090A1Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal IrinotecanIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 1088US2024342162A1Methods For Treating Pancreatic Cancer Using Combination TherapiesIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 1183US2024358706A1Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and OxaliplatinIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 1282US12364691B2Methods for treating pancreatic cancer using combination therapiesIPSEN BIOPHARM LTD·Filed 2022·Granted Jul 22, 2025·0 cites·5 claims
- 1377US2022096458A1Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal IrinotecanIPSEN BIOPHARM LTD·Filed 2021·Application pending·0 cites
- 1477US2025381191A1Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and OxaliplatinIPSEN BIOPHARM LTD·Filed 2025·Application pending·0 cites
- 1575US2023062425A1Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and OxaliplatinIPSEN BIOPHARM LTD·Filed 2022·Application pending·0 cites
- 1666US2017368056A1Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanIPSEN BIOPHARM LTD·Filed 2017·Application pending·0 cites
- 1766US2017049768A1Methods for treating pancreatic cancer using combination therapiesMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1864US2017065578A1Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1963US2018008591A1Methods for Treating Pancreatic Cancer Using Combination TherapiesIPSEN BIOPHARM LTD·Filed 2017·Application pending·0 cites
- 2063US2020360367A1Treatment of Breast Cancer with Liposomal IrinotecanIPSEN BIOPHARM LTD·Filed 2019·Application pending·0 cites
- 2162US2016228428A1Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2259US2019142822A1Treatment of Breast Cancer with Liposomal IrinotecanIPSEN BIOPHARM LTD·Filed 2018·Application pending·0 cites
- 2354US2017049775A1Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and OxaliplatinMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2452US2017151226A1Treatment of Breast Cancer with Liposomal IrinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2544US2017202840A1Treatment of pancreatic cancer with liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2640US2016346272A1Treatment of breast cancer with liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2733US2005272758A1Antineoplastic combinations of CCI-779 and rituximabWYETH CORP·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eliel Bayever files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →